Association for Accessible Medicines v. Becerra
Case Number:
2:19-cv-02281
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 06, 2020
Pay-For-Delay Ban Risks 'Endless Litigation,' 9th Circ. Told
Two trade groups and a public interest law firm on Thursday urged the Ninth Circuit to block a California state law prohibiting pay-for-delay deals between branded and generic-drug makers, saying the law could lead to never-ending litigation.
-
January 27, 2020
Pharma Cos. Push 9th Circ. To Pause Calif. Pay-For-Delay Law
A group of pharmaceutical companies challenging a new California law banning most pay-for-delay settlements between generic and branded drugmakers urged the Ninth Circuit to pause the ban's implementation, saying the measure clashes with court precedent and would subject them to lengthy patent litigation.
-
January 10, 2020
Calif. Pay-For-Delay Ban Won't Be Paused Pending Appeal
A California federal judge on Friday declined to temporarily block a new state law prohibiting pay-for-delay deals between branded and generic drug makers while a group of pharmaceutical companies appeals his earlier decision, ruling the group hadn't shown a likelihood of success in the Ninth Circuit.
-
January 02, 2020
California Pay-For-Delay Ban Headed To 9th Circ.
A group of generic pharmaceutical companies turned to the Ninth Circuit on Thursday after a district judge rejected their request to temporarily block a new California law prohibiting pay-for-delay deals between branded and generic-drug makers.
-
December 11, 2019
Calif. Fights Bid To Block Pay-For-Delay Law
California has fired back against a bid by a generic-drug industry trade group to enjoin a recently passed law that made the state the first in the nation to ban so-called pay-for-delay deals, saying the legislation is needed to preserve competition in the pharmaceutical industry.